Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis
Abstract Trastuzumab combined with chemotherapy is standard of care for HER2 positive advanced gastro-esophageal cancers. The reported prevalence of HER2 discordance between primary tumors and corresponding metastases varies, hampering uniform patient selection for HER2 targeted therapy. This meta-a...
Guardado en:
Autores principales: | A. Creemers, E. ter Veer, L. de Waal, P. Lodder, G. K. J. Hooijer, N. C. T. van Grieken, M. F. Bijlsma, S. L. Meijer, M. G. H. van Oijen, H. W. M. van Laarhoven |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/256dfbed0fe34b36901003d0614a20f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Frequency of ABO and Rh Blood Groups in Gastro Esophageal Reflux Disease
por: M Sadreddini, et al.
Publicado: (2011) -
Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis
por: Emil ter Veer, et al.
Publicado: (2017) -
4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease.
por: Johan Jirholt, et al.
Publicado: (2011) -
Mining the plasma-proteome associated genes in patients with gastro-esophageal cancers for biomarker discovery
por: Frederick S. Vizeacoumar, et al.
Publicado: (2021) -
Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives
por: Wolfgang Schröder, et al.
Publicado: (2021)